XPO1 and neoplasm: These presentations have discussed findings including: identifying progressive T-cell expansion across disease stages from folliculotropic MF to large cell transformation (LCT) [54], proposing exportin-1 (XPO1) as a potential target by highlighting therapeutic dependency in a single-cell atlas [55], exploring the gene expression patterns and tumor microenvironment interactions of malignant T cells [56,57,58], and exploring race and ethnicity related transcriptional differences in early MF [59].